National Health Investors, Inc. (NHI) Received Consensus Rating of “Hold” by Brokerages

National Health Investors, Inc. (NHI) Received Consensus Rating of “Hold” by Brokerages

Several research analysts recently commented on NHI shares. SunTrust Banks set a $75.00 price objective on shares of National Health Investors and gave the stock a “hold” rating in a research note on Monday, January 22nd. Cantor Fitzgerald reiterated a “hold” rating and set a $85.00 price objective on shares of National Health Investors in a research note on Wednesday, January 17th. BMO Capital Markets set a $70.00 price objective on shares of National Health Investors and gave the stock a “hold” rating in a research note on Monday, March 26th. ValuEngine lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Finally, Stifel Nicolaus set a $76.00 price objective on shares of National Health Investors and gave the stock a “buy” rating in a research note on Saturday, February 17th.

Shares of National Health Investors, Inc. (NYSE:NHI) have been assigned a consensus rating of “Hold” from the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $73.25.

Shares of NYSE NHI traded up $0.14 during trading hours on Thursday, hitting $65.65. 15,098 shares of the stock were exchanged, compared to its average volume of 258,553. The company has a quick ratio of 13.85, a current ratio of 13.85 and a debt-to-equity ratio of 0.87. The firm has a market cap of $2,725.75, a PE ratio of 12.29, a price-to-earnings-growth ratio of 3.40 and a beta of 0.42. National Health Investors has a 12 month low of $62.71 and a 12 month high of $81.60.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Friday, February 16th. The real estate investment trust reported $0.90 EPS for the quarter, missing the consensus estimate of $1.33 by ($0.43). The firm had revenue of $71.06 million for the quarter, compared to the consensus estimate of $71.36 million. National Health Investors had a return on equity of 12.20% and a net margin of 57.19%. equities research analysts anticipate that National Health Investors will post 5.5 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 10th. Shareholders of record on Friday, March 30th will be paid a dividend of $1.00 per share. This is a positive change from National Health Investors’s previous quarterly dividend of $0.95. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $4.00 dividend on an annualized basis and a yield of 6.09%. National Health Investors’s dividend payout ratio is presently 75.05%.

In other National Health Investors news, VP John L. Spaid acquired 500 shares of the company’s stock in a transaction dated Thursday, February 22nd. The shares were acquired at an average cost of $64.95 per share, with a total value of $32,475.00. Following the acquisition, the vice president now directly owns 971 shares of the company’s stock, valued at $63,066.45. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO D. Eric Mendelsohn acquired 2,000 shares of the company’s stock in a transaction dated Thursday, February 22nd. The stock was acquired at an average cost of $65.47 per share, for a total transaction of $130,940.00. Following the completion of the acquisition, the chief executive officer now directly owns 10,580 shares in the company, valued at $692,672.60. The disclosure for this purchase can be found here. Insiders have acquired a total of 2,812 shares of company stock worth $183,910 in the last 90 days. 5.63% of the stock is currently owned by company insiders.

Hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC boosted its holdings in shares of National Health Investors by 30.4% in the 4th quarter. Renaissance Technologies LLC now owns 471,700 shares of the real estate investment trust’s stock valued at $35,557,000 after acquiring an additional 110,000 shares during the last quarter. California Public Employees Retirement System boosted its holdings in shares of National Health Investors by 8.0% in the 3rd quarter. California Public Employees Retirement System now owns 87,839 shares of the real estate investment trust’s stock valued at $6,789,000 after acquiring an additional 6,539 shares during the last quarter. Swiss National Bank boosted its holdings in shares of National Health Investors by 1.9% in the 4th quarter. Swiss National Bank now owns 69,820 shares of the real estate investment trust’s stock valued at $5,263,000 after acquiring an additional 1,300 shares during the last quarter. Stephens Inc. AR purchased a new stake in shares of National Health Investors in the 4th quarter valued at $238,000. Finally, Teacher Retirement System of Texas boosted its holdings in shares of National Health Investors by 320.4% in the 4th quarter. Teacher Retirement System of Texas now owns 14,155 shares of the real estate investment trust’s stock valued at $1,067,000 after acquiring an additional 10,788 shares during the last quarter. 73.99% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Related posts

Leave a Comment